Search type: go_term
Results for query: receptor binding
| Gene Symbol | Gene Name | Links to Senescence |
|---|---|---|
| A2M | alpha-2-macroglobulin |
U: 3
D: 1
|
| ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 |
U: 4
D: 1
|
| ABCA12 | ATP-binding cassette, sub-family A (ABC1), member 12 |
U: 3
|
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase |
U: 1
|
| ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
U: 3
|
| ACTN4 | actinin alpha 4 |
U: 4
D: 2
|
| ADA2 | adenosine deaminase 2 | |
| ADAM10 | ADAM metallopeptidase domain 10 |
U: 3
D: 2
|
| ADAM15 | a disintegrin and metallopeptidase domain 15 (metargidin) |
U: 1
|
| ADAM17 | a disintegrin and metallopeptidase domain 17 |
U: 3
D: 2
|
| ADIPOQ | adiponectin, C1Q and collagen domain containing |
U: 2
D: 4
|
| ADM | adrenomedullin |
U: 4
D: 2
|
| ADORA1 | adenosine A1 receptor |
D: 1
|
| ADRA2A | adrenergic receptor, alpha 2a |
U: 2
|
| ADRA2C | adrenergic receptor, alpha 2c |
U: 2
|
| AGR2 | anterior gradient 2 |
D: 2
|
| AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
U: 4
D: 1
|
| AGTR1 | angiotensin II receptor type 1 |
U: 6
D: 2
|
| AIP | aryl-hydrocarbon receptor-interacting protein |
U: 1
|
| AKAP5 | A kinase (PRKA) anchor protein 5 |
U: 1
D: 1
|
| AKAP9 | A-kinase anchoring protein 9 |
U: 2
|
| ALCAM | activated leukocyte cell adhesion molecule |
U: 2
D: 1
|
| AMH | anti-Mullerian hormone |
D: 2
|
| ANG | angiogenin, ribonuclease, RNase A family, 5 |
U: 2
D: 1
|
| ANGPT1 | angiopoietin 1 |
U: 3
D: 3
|
| ANGPT2 | angiopoietin 2 |
U: 3
|
| ANGPT4 | angiopoietin 4 |
U: 1
|
| ANGPTL2 | angiopoietin-like 2 |
U: 3
D: 1
|
| ANGPTL4 | angiopoietin-like 4 |
U: 7
D: 1
|
| ANGPTL6 | angiopoietin-like 6 |
U: 1
|
| ANGPTL7 | angiopoietin-like 7 |
U: 1
D: 1
|
| ANKRA2 | ankyrin repeat, family A (RFXANK-like), 2 |
U: 1
|
| ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B |
D: 1
|
| ANO1 | anoctamin 1, calcium activated chloride channel |
U: 1
D: 2
|
| ANXA1 | annexin A1 |
U: 2
D: 1
|
| AP2A1 | adaptor-related protein complex 2, alpha 1 subunit |
U: 1
|
| AP2M1 | adaptor-related protein complex 2, mu 1 subunit |
U: 1
|
| APLN | apelin |
U: 1
D: 3
|
| APLP1 | amyloid beta (A4) precursor-like protein 1 |
U: 6
|
| APOA1 | apolipoprotein A-I |
U: 3
|
| APOB | apolipoprotein B |
D: 1
|
| APOC3 | apolipoprotein C-III |
U: 1
|
| APOE | apolipoprotein E |
U: 4
D: 2
|
| APOL2 | apolipoprotein L2 |
U: 3
D: 1
|
| APP | amyloid beta (A4) precursor protein |
U: 6
D: 2
|
| AR | androgen receptor |
U: 1
D: 1
|
| ARAP1 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
U: 2
|
| AREG | amphiregulin |
U: 2
D: 1
|
| ARF4 | ADP-ribosylation factor 4 |
U: 1
|
| ARFGEF2 | ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) |
U: 1
D: 1
|
| ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 |
U: 1
|
| ARID1A | AT rich interactive domain 1A (SWI-like) |
U: 1
|
| ARID5A | AT rich interactive domain 5A (MRF1-like) |
U: 2
D: 1
|
| ARNT | aryl hydrocarbon receptor nuclear translocator |
U: 1
D: 1
|
| ARNT2 | aryl hydrocarbon receptor nuclear translocator 2 |
U: 1
D: 3
|
| ARNTL | aryl hydrocarbon receptor nuclear translocator-like |
U: 2
D: 1
|
| ARRB1 | arrestin, beta 1 |
U: 2
D: 1
|
| ARRB2 | arrestin, beta 2 |
D: 1
|
| ARRDC3 | arrestin domain containing 3 |
D: 1
|
| ARTN | artemin |
D: 2
|
| ASXL1 | additional sex combs like 1 |
D: 3
|
| ASXL2 | additional sex combs like 2, transcriptional regulator |
D: 1
|
| ATP2A2 | ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
U: 3
D: 2
|
| ATP2A3 | ATPase, Ca++ transporting, ubiquitous |
U: 3
|
| ATXN2 | ataxin 2 |
D: 1
|
| AVPR1A | arginine vasopressin receptor 1A |
U: 1
|
| ACVR1C | activin A receptor, type IC |
U: 1
|
| ADCY6 | adenylate cyclase 6 |
U: 4
|
| ADD1 | adducin 1 (alpha) |
U: 1
|
| ADRB2 | adrenergic receptor, beta 2 |
U: 1
D: 1
|
| AHR | aryl-hydrocarbon receptor |
U: 3
D: 2
|
| AQP1 | aquaporin 1 |
U: 2
D: 3
|
| ARPC2 | actin related protein 2/3 complex, subunit 2 |
U: 2
D: 1
|
| ASAH1 | N-acylsphingosine amidohydrolase 1 |
U: 2
D: 2
|
| ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide |
U: 2
|
| AXIN1 | axin 1 |
U: 1
D: 1
|
| B2M | beta-2 microglobulin |
U: 5
D: 1
|
| BABAM2 | BRISC and BRCA1 A complex member 2 |
U: 1
D: 1
|
| BAMBI | BMP and activin membrane bound inhibitor |
U: 2
|
| BANK1 | B cell scaffold protein with ankyrin repeats 1 |
U: 2
|
| BAZ2A | bromodomain adjacent to zinc finger domain 2A |
U: 2
D: 1
|
| BCAS3 | breast carcinoma amplified sequence 3 |
U: 2
D: 1
|
| BDNF | brain derived neurotrophic factor |
U: 1
|
| BEX1 | brain expressed X-linked 1 |
U: 1
|
| BEX2 | brain expressed X-linked 2 |
U: 1
|
| BEX3 | brain expressed X-linked 3 |
U: 2
|
| BICD1 | BICD cargo adaptor 1 |
D: 2
|
| BID | BH3 interacting domain death agonist |
U: 5
|
| BLK | B lymphoid kinase |
U: 1
|
| BMP2 | bone morphogenetic protein 2 |
U: 6
D: 1
|
| BMP3 | bone morphogenetic protein 3 |
D: 1
|
| BMP4 | bone morphogenetic protein 4 |
U: 5
D: 1
|
| BMP5 | bone morphogenetic protein 5 |
D: 3
|
| BMP6 | bone morphogenetic protein 6 |
U: 2
D: 1
|
| BMP7 | bone morphogenetic protein 7 |
U: 5
D: 3
|
| BMP8A | bone morphogenetic protein 8a |
U: 1
|
| BMP8B | bone morphogenetic protein 8b |
U: 1
|
| BOK | BCL2-related ovarian killer |
U: 3
D: 1
|
| BRCA1 | BRCA1 DNA repair associated |
U: 2
D: 10
|
| BTC | betacellulin, epidermal growth factor family member |
U: 2
|
| BTN2A1 | butyrophilin subfamily 2 member A1 |
U: 1
D: 1
|
| BTN2A2 | butyrophilin, subfamily 2, member A2 |
U: 1
|
| BTN2A3P | butyrophilin subfamily 2 member A3, pseudogene |
D: 1
|
| BTN3A1 | butyrophilin subfamily 3 member A1 |
U: 2
|
| BTN3A2 | butyrophilin subfamily 3 member A2 |
U: 1
D: 1
|
| BTN3A3 | butyrophilin subfamily 3 member A3 |
U: 2
D: 2
|
| BUD31 | BUD31 homolog |
D: 1
|
| C10ORF99 | chromosome 10 open reading frame 99 |
U: 1
|
| C1QBP | complement component 1, q subcomponent binding protein |
U: 1
D: 3
|
| C1QL1 | complement component 1, q subcomponent-like 1 |
U: 3
D: 2
|
| C1QTNF2 | C1q and tumor necrosis factor related protein 2 |
U: 1
D: 2
|
| C3 | complement C3 |
U: 9
D: 1
|
| C5 | complement C5 |
U: 1
D: 4
|
| CACNG4 | calcium channel, voltage-dependent, gamma subunit 4 |
D: 2
|
| CADM1 | cell adhesion molecule 1 |
U: 2
D: 1
|
| CALCA | calcitonin/calcitonin-related polypeptide, alpha |
D: 3
|
| CALCB | calcitonin-related polypeptide, beta |
D: 1
|
| CALM3 | calmodulin 3 |
D: 2
|
| CALR | calreticulin |
D: 3
|
| CAMK2A | calcium/calmodulin-dependent protein kinase II alpha |
U: 1
D: 3
|
| CANX | calnexin |
U: 1
D: 2
|
| CAPRIN2 | caprin family member 2 |
D: 1
|
| CASP3 | caspase 3 |
U: 3
D: 5
|
| CASP8 | caspase 8 |
U: 1
D: 2
|
| CASP8AP2 | caspase 8 associated protein 2 |
D: 3
|
| CAV1 | caveolin 1, caveolae protein |
U: 15
D: 7
|
| CBL | Casitas B-lineage lymphoma |
U: 1
D: 1
|
| CBLC | Casitas B-lineage lymphoma c |
U: 1
D: 1
|
| CCDC62 | coiled-coil domain containing 62 |
U: 2
|
| CCDC88A | coiled coil domain containing 88A |
D: 2
|
| CCL1 | chemokine (C-C motif) ligand 1 |
U: 3
|
| CCL11 | chemokine (C-C motif) ligand 11 |
U: 5
D: 1
|
| CCL13 | C-C motif chemokine ligand 13 |
U: 2
D: 1
|
| CCL17 | chemokine (C-C motif) ligand 17 |
U: 1
D: 1
|
| CCL2 | chemokine (C-C motif) ligand 2 |
U: 39
D: 6
|
| CCL20 | chemokine (C-C motif) ligand 20 |
U: 9
|
| CCL26 | chemokine (C-C motif) ligand 26 |
U: 1
|
| CCL27 | C-C motif chemokine ligand 27 |
D: 1
|
| CCL3 | chemokine (C-C motif) ligand 3 |
U: 11
D: 1
|
| CCL3L3 | C-C motif chemokine ligand 3 like 3 |
U: 2
|
| CCL4 | chemokine (C-C motif) ligand 4 |
U: 5
|
| CCL5 | chemokine (C-C motif) ligand 5 |
U: 13
D: 1
|
| CCL7 | chemokine (C-C motif) ligand 7 |
U: 7
|
| CCL8 | chemokine (C-C motif) ligand 8 |
U: 5
|
| CCNE1 | cyclin E1 |
U: 6
D: 1
|
| CD276 | CD276 antigen |
U: 1
D: 1
|
| CD2AP | CD2-associated protein |
U: 2
|
| CD36 | CD36 molecule |
U: 4
D: 2
|
| CD40LG | CD40 ligand |
U: 1
|
| CD58 | CD58 molecule |
U: 1
|
| CD70 | CD70 antigen |
U: 1
|
| CD72 | CD72 molecule |
U: 2
|
| CD74 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) |
D: 4
|
| CD81 | CD81 antigen |
U: 2
D: 1
|
| CDC42 | cell division cycle 42 |
U: 3
|
| CDH5 | cadherin 5 |
U: 1
D: 3
|
| CDK5 | cyclin-dependent kinase 5 |
U: 3
|
| CDK5R1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
U: 2
D: 2
|
| CDK7 | cyclin dependent kinase 7 |
U: 1
D: 1
|
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta |
U: 9
D: 1
|
| CFL1 | cofilin 1, non-muscle |
D: 2
|
| CFLAR | CASP8 and FADD-like apoptosis regulator |
U: 1
D: 1
|
| CHN1 | chimerin 1 |
D: 3
|
| CHRNA10 | cholinergic receptor nicotinic alpha 10 subunit |
U: 1
|
| CHUK | conserved helix-loop-helix ubiquitous kinase |
U: 2
D: 2
|
| CLCF1 | cardiotrophin-like cytokine factor 1 |
U: 1
|
| CLIC6 | chloride intracellular channel 6 |
U: 2
|
| CLTC | clathrin, heavy polypeptide (Hc) |
U: 1
|
| CLU | clusterin |
U: 3
D: 5
|
| CNIH4 | cornichon family AMPA receptor auxiliary protein 4 |
U: 1
D: 2
|
| CNOT9 | CCR4-NOT transcription complex, subunit 9 | |
| CNPY3 | canopy FGF signaling regulator 3 |
U: 1
D: 1
|
| CNPY4 | canopy FGF signaling regulator 4 |
U: 1
|
| CNRIP1 | cannabinoid receptor interacting protein 1 |
D: 1
|
| CNTFR | ciliary neurotrophic factor receptor |
U: 1
D: 1
|
| CORT | cortistatin |
U: 1
|
| CRH | corticotropin releasing hormone |
D: 1
|
| CRLF1 | cytokine receptor-like factor 1 |
U: 3
D: 2
|
| CRP | C-reactive protein, pentraxin-related |
U: 1
|
| CRTAC1 | cartilage acidic protein 1 |
U: 1
|
| CRY1 | cryptochrome 1 (photolyase-like) |
D: 1
|
| CSF1 | colony stimulating factor 1 (macrophage) |
U: 5
|
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) |
U: 11
D: 2
|
| CSF3 | colony stimulating factor 3 (granulocyte) |
U: 7
D: 1
|
| CSH2 | chorionic somatomammotropin hormone 2 | |
| CSNK2B | casein kinase 2, beta polypeptide |
U: 1
|
| CTBP2 | C-terminal binding protein 2 |
D: 2
|
| CTF1 | cardiotrophin 1 |
U: 1
|
| CTNNB1 | catenin (cadherin associated protein), beta 1 |
U: 7
D: 2
|
| CTNND1 | catenin (cadherin associated protein), delta 1 |
D: 2
|
| CX3CL1 | chemokine (C-X3-C motif) ligand 1 |
U: 4
|
| CXCL1 | chemokine (C-X-C motif) ligand 1 |
U: 27
D: 7
|
| CXCL10 | chemokine (C-X-C motif) ligand 10 |
U: 11
|
| CXCL11 | chemokine (C-X-C motif) ligand 11 |
U: 3
|
| CXCL12 | chemokine (C-X-C motif) ligand 12 |
U: 4
D: 5
|
| CXCL13 | chemokine (C-X-C motif) ligand 13 |
U: 2
|
| CXCL2 | chemokine (C-X-C motif) ligand 2 |
U: 16
D: 5
|
| CXCL3 | chemokine (C-X-C motif) ligand 3 |
U: 5
D: 1
|
| CXCL5 | chemokine (C-X-C motif) ligand 5 |
U: 9
D: 1
|
| CXCL6 | C-X-C motif chemokine ligand 6 |
U: 7
|
| CXCL8 | C-X-C motif chemokine ligand 8 |
U: 49
D: 11
|
| CXCL9 | chemokine (C-X-C motif) ligand 9 |
U: 3
|
| CYTL1 | cytokine like 1 |
U: 1
D: 1
|
| CACNG8 | calcium channel, voltage-dependent, gamma subunit 8 |
U: 1
|
| CALM1 | calmodulin 1 |
U: 1
D: 1
|
| CAPN3 | calpain 3 |
U: 1
|
| CAV2 | caveolin 2 |
U: 3
D: 2
|
| CCL9 | chemokine (C-C motif) ligand 9 |
U: 1
|
| CD4 | CD4 antigen |
D: 1
|
| CD44 | CD44 antigen |
U: 6
D: 2
|
| CD86 | CD86 antigen |
U: 1
|
| CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 |
U: 2
|
| CREB3 | cAMP responsive element binding protein 3 |
U: 1
|
| CREBBP | CREB binding protein |
U: 1
D: 2
|
| CRY2 | cryptochrome 2 (photolyase-like) |
U: 1
|
| CXADR | coxsackie virus and adenovirus receptor |
U: 4
|
| CXCL16 | chemokine (C-X-C motif) ligand 16 |
U: 6
D: 1
|
| DAB2IP | disabled 2 interacting protein |
U: 1
D: 1
|
| DAXX | Fas death domain-associated protein |
D: 1
|
| DBI | diazepam binding inhibitor |
D: 1
|
| DCAF1 | DDB1 and CUL4 associated factor 1 |
D: 1
|
| DCAF13 | DDB1 and CUL4 associated factor 13 |
D: 2
|
| DDT | D-dopachrome tautomerase |
U: 1
|
| DDX5 | DEAD box helicase 5 |
D: 3
|
| DDX54 | DEAD box helicase 54 |
D: 1
|
| DIAPH2 | diaphanous related formin 2 |
U: 1
|
| DKK1 | dickkopf WNT signaling pathway inhibitor 1 |
U: 7
D: 2
|
| DKK2 | dickkopf WNT signaling pathway inhibitor 2 |
U: 4
|
| DKK3 | dickkopf WNT signaling pathway inhibitor 3 |
U: 5
D: 1
|
| DLG3 | discs large MAGUK scaffold protein 3 |
D: 3
|
| DLG4 | discs large MAGUK scaffold protein 4 |
U: 1
D: 2
|
| DMTN | dematin actin binding protein |
U: 1
|
| DNAJA1 | DnaJ heat shock protein family (Hsp40) member A1 |
U: 1
D: 2
|
| DNM1 | dynamin 1 |
U: 1
D: 1
|
| DNM2 | dynamin 2 |
U: 1
|
| DNM3 | dynamin 3 |
D: 1
|
| DPP4 | dipeptidylpeptidase 4 |
U: 10
D: 2
|
| DRD2 | dopamine receptor D2 |
U: 1
|
| DAB2 | disabled 2, mitogen-responsive phosphoprotein |
U: 2
D: 2
|
| DLG1 | discs large MAGUK scaffold protein 1 |
U: 1
|
| DNAJB11 | DnaJ heat shock protein family (Hsp40) member B11 |
D: 1
|
| DNMT1 | DNA methyltransferase (cytosine-5) 1 |
U: 2
D: 7
|
| DRD1 | dopamine receptor D1 |
D: 2
|
| DUT | deoxyuridine triphosphatase |
D: 3
|
| ECM1 | extracellular matrix protein 1 |
U: 4
|
| EDN1 | endothelin 1 |
U: 5
D: 1
|
| EDN2 | endothelin 2 |
U: 2
|
| EDNRB | endothelin receptor type B |
U: 1
D: 2
|
| EFEMP1 | epidermal growth factor-containing fibulin-like extracellular matrix protein 1 |
U: 4
D: 1
|
| EFNA1 | ephrin A1 |
U: 2
|
| EFNA2 | ephrin A2 |
U: 1
D: 1
|
| EFNA3 | ephrin A3 |
U: 1
|
| EFNA4 | ephrin A4 |
U: 1
D: 1
|
| EFNA5 | ephrin A5 |
U: 2
D: 2
|
| EFNB1 | ephrin B1 |
U: 1
|
| EFNB2 | ephrin B2 |
U: 1
D: 1
|
| EFNB3 | ephrin B3 |
U: 2
D: 3
|
| EGF | epidermal growth factor |
U: 4
D: 5
|
| EGFL7 | EGF-like domain 7 |
U: 1
D: 2
|
| ELAPOR2 | endosome-lysosome associated apoptosis and autophagy regulator family member 2 | |
| EML2 | echinoderm microtubule associated protein like 2 |
U: 2
|
| ENG | endoglin |
U: 4
D: 5
|
| ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 |
U: 2
D: 2
|
| ENSA | endosulfine alpha |
D: 1
|
| EP300 | E1A binding protein p300 |
U: 3
D: 6
|
| EPGN | epithelial mitogen |
U: 1
D: 1
|
| EPHA4 | Eph receptor A4 |
U: 1
D: 1
|
| EPHA7 | Eph receptor A7 |
D: 2
|
| EPHB2 | Eph receptor B2 |
U: 2
D: 3
|
| EPS8L1 | EPS8-like 1 |
U: 1
|
| ERAP1 | endoplasmic reticulum aminopeptidase 1 |
D: 1
|
| ERBB2 | erb-b2 receptor tyrosine kinase 2 |
U: 9
|
| ERBB3 | erb-b2 receptor tyrosine kinase 3 |
U: 1
D: 1
|
| ERBB4 | erb-b2 receptor tyrosine kinase 4 |
U: 2
D: 1
|
| ERBIN | Erbb2 interacting protein |
U: 2
D: 2
|
| EREG | epiregulin |
U: 3
D: 3
|
| ERMAP | erythroblast membrane-associated protein |
U: 1
|
| ERN1 | endoplasmic reticulum (ER) to nucleus signalling 1 |
U: 3
D: 2
|
| ESM1 | endothelial cell-specific molecule 1 |
U: 3
D: 1
|
| ESR1 | estrogen receptor 1 (alpha) |
U: 2
D: 4
|
| ETS2 | E26 avian leukemia oncogene 2, 3' domain |
U: 4
D: 2
|
| EBI3 | Epstein-Barr virus induced gene 3 |
U: 4
|
| EDARADD | EDAR (ectodysplasin-A receptor)-associated death domain |
D: 2
|
| EGFR | epidermal growth factor receptor |
U: 2
D: 11
|
| EPB41L1 | erythrocyte membrane protein band 4.1 like 1 |
U: 2
|
| ESR2 | estrogen receptor 2 (beta) |
U: 2
D: 1
|
| F2 | coagulation factor II, thrombin |
U: 2
|
| F2R | coagulation factor II (thrombin) receptor |
U: 2
D: 1
|
| F2RL1 | F2R like trypsin receptor 1 |
U: 2
D: 1
|
| FABP4 | fatty acid binding protein 4, adipocyte |
D: 4
|
| FASLG | Fas ligand |
U: 3
|
| FER | fer (fms/fps related) protein kinase |
D: 2
|
| FGF1 | fibroblast growth factor 1 |
U: 3
D: 2
|
| FGF10 | fibroblast growth factor 10 |
D: 1
|
| FGF17 | fibroblast growth factor 17 |
D: 1
|
| FGF18 | fibroblast growth factor 18 |
U: 3
|
| FGF2 | fibroblast growth factor 2 |
U: 14
D: 6
|
| FGF4 | fibroblast growth factor 4 | |
| FGF5 | fibroblast growth factor 5 |
U: 2
D: 1
|
| FGF7 | fibroblast growth factor 7 |
D: 1
|
| FGL2 | fibrinogen-like protein 2 |
D: 2
|
| FHL2 | four and a half LIM domains 2 |
U: 3
|
| FIBCD1 | fibrinogen C domain containing 1 |
U: 1
D: 1
|
| FKBP1A | FK506 binding protein 1a |
U: 1
|
| FKBP1B | FK506 binding protein 1b |
U: 1
|
| FLNA | filamin, alpha |
U: 1
D: 3
|
| FLOT1 | flotillin 1 |
U: 1
D: 1
|
| FLOT2 | flotillin 2 |
D: 1
|
| FLT3LG | fms related receptor tyrosine kinase 3 ligand |
U: 2
|
| FN1 | fibronectin 1 |
U: 9
D: 5
|
| FOXL2 | forkhead box L2 |
U: 1
|
| FOXP1 | forkhead box P1 |
U: 2
D: 3
|
| FOXP2 | forkhead box P2 |
U: 2
|
| FPR1 | formyl peptide receptor 1 |
U: 1
|
| FRK | fyn-related kinase |
D: 1
|
| FUS | fused in sarcoma |
U: 1
D: 1
|
| FYB1 | FYN binding protein 1 |
D: 1
|
| FYN | Fyn proto-oncogene |
D: 2
|
| FZD1 | frizzled class receptor 1 |
D: 2
|
| FZD8 | frizzled class receptor 8 |
U: 2
D: 2
|
| FGF12 | fibroblast growth factor 12 |
U: 1
D: 1
|
| FGF14 | fibroblast growth factor 14 |
U: 2
|
| FGFR1 | fibroblast growth factor receptor 1 |
U: 2
|
| FLRT1 | fibronectin leucine rich transmembrane protein 1 |
U: 1
|
| FLRT2 | fibronectin leucine rich transmembrane protein 2 |
U: 2
|
| FLRT3 | fibronectin leucine rich transmembrane protein 3 |
U: 2
D: 1
|
| GABARAP | gamma-aminobutyric acid receptor associated protein |
U: 1
|
| GABARAPL1 | gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 |
U: 1
D: 1
|
| GABARAPL2 | GABA type A receptor associated protein like 2 |
U: 2
|
| GABRA5 | gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 |
U: 1
D: 1
|
| GABRB1 | gamma-aminobutyric acid (GABA) A receptor, subunit beta 1 |
U: 1
|
| GAL | galanin and GMAP prepropeptide |
U: 2
|
| GAS6 | growth arrest specific 6 |
U: 3
D: 4
|
| GATA3 | GATA binding protein 3 |
U: 1
|
| GBA | glucosidase, beta, acid |
U: 3
D: 1
|
| GCG | glucagon |
D: 1
|
| GDF15 | growth differentiation factor 15 |
U: 11
D: 1
|
| GDNF | glial cell line derived neurotrophic factor |
U: 5
|
| GFRA1 | GDNF family receptor alpha 1 |
U: 1
D: 1
|
| GH1 | growth hormone 1 |
U: 2
|
| GIPC1 | GIPC PDZ domain containing family, member 1 |
U: 2
|
| GLA | galactosidase, alpha |
U: 2
D: 2
|
| GLG1 | golgi glycoprotein 1 | |
| GLMN | glomulin, FKBP associated protein |
D: 1
|
| GNA11 | guanine nucleotide binding protein, alpha 11 |
U: 1
|
| GNA13 | guanine nucleotide binding protein, alpha 13 |
U: 2
|
| GNA14 | guanine nucleotide binding protein, alpha 14 |
U: 1
|
| GNA15 | guanine nucleotide binding protein, alpha 15 |
D: 1
|
| GNAI1 | guanine nucleotide binding protein (G protein), alpha inhibiting 1 |
U: 1
|
| GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting 2 |
U: 1
D: 2
|
| GNAI3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 |
D: 1
|
| GNAL | guanine nucleotide binding protein, alpha stimulating, olfactory type |
U: 1
|
| GNAO1 | guanine nucleotide binding protein, alpha O |
U: 3
D: 1
|
| GNAZ | guanine nucleotide binding protein, alpha z subunit |
U: 1
|
| GNRH1 | gonadotropin releasing hormone 1 |
D: 1
|
| GPRC5B | G protein-coupled receptor class C group 5 member B |
U: 1
D: 1
|
| GRB10 | growth factor receptor bound protein 10 |
D: 3
|
| GRIN1 | glutamate receptor, ionotropic, NMDA1 (zeta 1) |
U: 1
|
| GRIP1 | glutamate receptor interacting protein 1 |
U: 2
|
| GSTM2 | glutathione S-transferase mu 2 |
U: 1
|
| GTF2B | general transcription factor IIB |
D: 1
|
| GUSB | glucuronidase, beta |
U: 2
D: 3
|
| GDF5 | growth differentiation factor 5 |
U: 1
D: 1
|
| GJA1 | gap junction protein, alpha 1 |
U: 2
D: 2
|
| GPHN | gephyrin |
U: 1
D: 1
|
| GRIA2 | glutamate receptor, ionotropic, AMPA2 (alpha 2) |
D: 1
|
| GRIN2A | glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
U: 1
|
| GRK3 | G protein-coupled receptor kinase 3 |
D: 1
|
| GSK3B | glycogen synthase kinase 3 beta |
U: 1
D: 6
|
| HAP1 | huntingtin-associated protein 1 |
U: 1
D: 1
|
| HBEGF | heparin-binding EGF-like growth factor |
U: 3
D: 3
|
| HCST | hematopoietic cell signal transducer |
U: 1
|
| HFE | homeostatic iron regulator |
D: 1
|
| HIF1A | hypoxia inducible factor 1, alpha subunit |
U: 4
D: 8
|
| HIP1 | huntingtin interacting protein 1 |
U: 1
D: 1
|
| HLA-A | major histocompatibility complex, class I, A |
U: 3
D: 1
|
| HLA-B | major histocompatibility complex, class I, B |
U: 3
D: 2
|
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
U: 2
D: 2
|
| HLA-E | major histocompatibility complex, class I, E |
U: 3
D: 2
|
| HLA-F | major histocompatibility complex, class I, F |
U: 3
D: 2
|
| HLA-G | major histocompatibility complex, class I, G |
U: 1
|
| HMGA1 | high mobility group AT-hook 1 |
U: 4
D: 5
|
| HMGB1 | high mobility group box 1 |
U: 5
D: 8
|
| HMGB2 | high mobility group box 2 |
U: 1
D: 9
|
| HMGN3 | high mobility group nucleosomal binding domain 3 |
U: 1
D: 2
|
| HNF4A | hepatic nuclear factor 4, alpha |
U: 2
|
| HOMER1 | homer scaffolding protein 1 |
U: 1
|
| HOMER2 | homer scaffolding protein 2 |
D: 2
|
| HOMER3 | homer scaffolding protein 3 |
U: 2
D: 1
|
| HOXA3 | homeobox A3 |
U: 1
D: 1
|
| HSP90AB1 | heat shock protein 90 alpha (cytosolic), class B member 1 |
U: 1
D: 2
|
| HSP90B1 | heat shock protein 90, beta (Grp94), member 1 |
U: 2
D: 1
|
| HSPA1A | heat shock protein 1A |
U: 4
D: 7
|
| HSPA1B | heat shock protein family A (Hsp70) member 1B |
U: 3
D: 3
|
| HSPA8 | heat shock protein 8 |
U: 2
D: 1
|
| HSPG2 | heparan sulfate proteoglycan 2 |
U: 3
D: 1
|
| HR | lysine demethylase and nuclear receptor corepressor |
U: 1
D: 2
|
| HSD17B10 | hydroxysteroid (17-beta) dehydrogenase 10 |
D: 1
|
| HSD17B7 | hydroxysteroid (17-beta) dehydrogenase 7 |
U: 1
D: 1
|
| HSP90AA1 | heat shock protein 90, alpha (cytosolic), class A member 1 |
U: 3
D: 4
|
| ICOSLG | inducible T cell costimulator ligand |
U: 1
|
| IDUA | iduronidase, alpha-L |
U: 4
|
| IFNA1 | interferon alpha 1 |
U: 1
|
| IFNB1 | interferon beta 1, fibroblast |
U: 2
|
| IFNE | interferon epsilon |
U: 2
D: 1
|
| IFNG | interferon gamma |
U: 13
|
| IGF1 | insulin-like growth factor 1 |
U: 12
D: 7
|
| IGF1R | insulin-like growth factor I receptor |
U: 9
D: 4
|
| IGF2 | insulin-like growth factor 2 |
U: 3
D: 2
|
| IGFBP1 | insulin like growth factor binding protein 1 |
U: 6
|
| IGFBP2 | insulin like growth factor binding protein 2 |
U: 11
|
| IGFBP4 | insulin like growth factor binding protein 4 |
U: 6
D: 2
|
| IGFBP6 | insulin like growth factor binding protein 6 |
U: 4
D: 5
|
| IGFL3 | IGF-like family member 3 |
U: 2
|
| IGSF11 | immunoglobulin superfamily, member 11 |
D: 1
|
| IKBKB | inhibitor of kappaB kinase beta |
U: 2
D: 1
|
| IKBKG | inhibitor of kappaB kinase gamma |
D: 1
|
| IL10 | interleukin 10 |
U: 4
D: 3
|
| IL11 | interleukin 11 |
U: 3
D: 4
|
| IL12A | interleukin 12a |
U: 5
|
| IL13 | interleukin 13 |
U: 3
|
| IL13RA1 | interleukin 13 receptor, alpha 1 |
U: 1
D: 1
|
| IL15 | interleukin 15 |
U: 5
D: 1
|
| IL16 | interleukin 16 |
U: 1
D: 3
|
| IL17RA | interleukin 17 receptor A |
U: 2
|
| IL17RC | interleukin 17 receptor C |
U: 2
D: 1
|
| IL18 | interleukin 18 |
U: 8
D: 1
|
| IL1A | interleukin 1 alpha |
U: 31
D: 6
|
| IL1B | interleukin 1 beta |
U: 48
D: 9
|
| IL1R1 | interleukin 1 receptor, type I |
U: 1
D: 1
|
| IL1RAP | interleukin 1 receptor accessory protein |
U: 3
D: 2
|
| IL1RAPL1 | interleukin 1 receptor accessory protein-like 1 |
U: 1
D: 1
|
| IL1RN | interleukin 1 receptor antagonist |
U: 4
D: 1
|
| IL2 | interleukin 2 |
U: 3
D: 2
|
| IL20 | interleukin 20 |
U: 1
|
| IL22 | interleukin 22 |
U: 2
D: 1
|
| IL23A | interleukin 23, alpha subunit p19 |
U: 5
D: 1
|
| IL23R | interleukin 23 receptor |
U: 1
|
| IL27RA | interleukin 27 receptor, alpha |
U: 2
D: 1
|
| IL3 | interleukin 3 |
U: 1
|
| IL33 | interleukin 33 |
U: 1
D: 2
|
| IL34 | interleukin 34 |
U: 2
D: 1
|
| IL36B | interleukin 36 beta |
U: 1
|
| IL36RN | interleukin 36 receptor antagonist |
U: 2
|
| IL4 | interleukin 4 |
U: 4
|
| IL5 | interleukin 5 |
U: 1
|
| IL6 | interleukin 6 |
U: 97
D: 20
|
| IL6R | interleukin 6 receptor |
U: 2
D: 1
|
| IL6ST | interleukin 6 signal transducer |
U: 2
D: 1
|
| IL7 | interleukin 7 |
U: 5
|
| IL9 | interleukin 9 |
D: 1
|
| INHA | inhibin alpha |
U: 2
|
| INHBA | inhibin beta-A |
U: 4
D: 1
|
| INHBB | inhibin subunit beta B |
U: 3
D: 2
|
| INSR | insulin receptor |
U: 2
D: 2
|
| IRAK4 | interleukin-1 receptor-associated kinase 4 |
U: 1
|
| IRS1 | insulin receptor substrate 1 |
U: 2
D: 3
|
| IRS2 | insulin receptor substrate 2 |
U: 1
|
| ITGA1 | integrin alpha 1 |
D: 4
|
| ITGA5 | integrin alpha 5 (fibronectin receptor alpha) |
U: 3
D: 2
|
| ITGB3 | integrin subunit beta 3 |
U: 5
D: 2
|
| ITGB4 | integrin beta 4 |
U: 5
D: 3
|
| ITPRID2 | ITPR interacting domain containing 2 | |
| INS1 | insulin I |
D: 1
|
| IPO13 | importin 13 |
U: 2
|
| IRAK1 | interleukin-1 receptor-associated kinase 1 |
U: 2
D: 3
|
| ITGAV | integrin alpha V |
U: 2
D: 1
|
| ITGB1 | integrin beta 1 (fibronectin receptor beta) |
U: 3
D: 1
|
| ITGB5 | integrin beta 5 |
U: 2
D: 2
|
| ITGB8 | integrin beta 8 |
U: 3
D: 2
|
| JAK1 | Janus kinase 1 |
U: 3
D: 1
|
| JAK2 | Janus kinase 2 |
U: 3
|
| JMJD1C | jumonji domain containing 1C |
U: 1
|
| JUND | jun D proto-oncogene |
D: 1
|
| JUP | junction plakoglobin |
U: 2
|
| KAT5 | lysine acetyltransferase 5 |
U: 1
D: 1
|
| KDM1A | lysine (K)-specific demethylase 1A |
D: 3
|
| KDM3A | lysine (K)-specific demethylase 3A |
D: 1
|
| KDM4C | lysine (K)-specific demethylase 4C |
U: 1
D: 2
|
| KISS1 | KiSS-1 metastasis-suppressor |
U: 2
|
| KITLG | KIT ligand |
D: 3
|
| KL | klotho |
U: 2
D: 10
|
| KNG1 | kininogen 1 |
U: 2
|
| KCNJ10 | potassium inwardly-rectifying channel, subfamily J, member 10 |
D: 1
|
| KCNJ8 | potassium inwardly-rectifying channel, subfamily J, member 8 |
U: 1
D: 4
|
| KIF5C | kinesin family member 5C |
U: 1
D: 1
|
| LAMA1 | laminin, alpha 1 |
D: 2
|
| LAMA2 | laminin, alpha 2 |
U: 2
D: 2
|
| LAMA4 | laminin, alpha 4 |
U: 1
D: 3
|
| LAMC2 | laminin, gamma 2 |
U: 2
D: 3
|
| LANCL1 | LanC (bacterial lantibiotic synthetase component C)-like 1 |
U: 1
|
| LATS1 | large tumor suppressor |
D: 2
|
| LCK | lymphocyte protein tyrosine kinase |
U: 1
|
| LDLRAP1 | low density lipoprotein receptor adaptor protein 1 |
U: 2
D: 1
|
| LEF1 | lymphoid enhancer binding factor 1 |
U: 1
|
| LEFTY1 | left right determination factor 1 |
D: 1
|
| LEFTY2 | left-right determination factor 2 |
D: 1
|
| LEP | leptin |
U: 3
D: 1
|
| LIF | leukemia inhibitory factor |
U: 6
D: 3
|
| LIFR | LIF receptor alpha |
D: 3
|
| LMBRD1 | LMBR1 domain containing 1 |
U: 1
|
| LOX | lysyl oxidase |
U: 2
D: 4
|
| LPL | lipoprotein lipase |
U: 1
D: 3
|
| LRIF1 | ligand dependent nuclear receptor interacting factor 1 |
U: 1
|
| LRIG2 | leucine-rich repeats and immunoglobulin-like domains 2 |
D: 1
|
| LRP1 | LDL receptor related protein 1 |
U: 3
D: 1
|
| LRP6 | low density lipoprotein receptor-related protein 6 |
D: 1
|
| LRPAP1 | low density lipoprotein receptor-related protein associated protein 1 |
U: 2
|
| LRRC4B | leucine rich repeat containing 4B |
U: 1
|
| LRRK2 | leucine rich repeat kinase 2 |
U: 1
|
| LTA | lymphotoxin A |
U: 1
|
| LTB | lymphotoxin B |
U: 1
|
| LY6H | lymphocyte antigen 6 complex, locus H |
D: 1
|
| LYN | LYN proto-oncogene, Src family tyrosine kinase |
D: 1
|
| LYNX1 | Ly6/neurotoxin 1 |
U: 2
D: 1
|
| LYPD1 | Ly6/Plaur domain containing 1 |
U: 1
D: 1
|
| LAMA3 | laminin, alpha 3 |
U: 2
D: 1
|
| LAMA5 | laminin, alpha 5 |
U: 6
D: 2
|
| LGALS9 | lectin, galactose binding, soluble 9 |
U: 3
D: 2
|
| LPIN1 | lipin 1 |
U: 1
D: 1
|
| LRP2 | low density lipoprotein receptor-related protein 2 |
U: 1
|
| LY6E | lymphocyte antigen 6 complex, locus E |
U: 1
D: 1
|
| MBL2 | mannose-binding lectin (protein C) 2 |
D: 1
|
| MCHR1 | melanin-concentrating hormone receptor 1 |
U: 2
|
| MDM2 | transformed mouse 3T3 cell double minute 2 |
U: 6
D: 18
|
| MED12 | mediator complex subunit 12 |
D: 1
|
| MED13 | mediator complex subunit 13 |
D: 1
|
| MED14 | mediator complex subunit 14 |
U: 1
D: 1
|
| MED16 | mediator complex subunit 16 |
D: 2
|
| MED30 | mediator complex subunit 30 |
D: 1
|
| MED4 | mediator complex subunit 4 |
U: 1
D: 1
|
| MESD | mesoderm development LRP chaperone |
D: 1
|
| MFAP4 | microfibrillar-associated protein 4 |
U: 1
D: 3
|
| MICA | MHC class I polypeptide-related sequence A |
U: 4
D: 1
|
| MICB | MHC class I polypeptide-related sequence B |
U: 4
D: 1
|
| MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
U: 3
D: 5
|
| MMP9 | matrix metallopeptidase 9 |
U: 14
D: 3
|
| MR1 | major histocompatibility complex, class I-related |
U: 3
|
| MRAP2 | melanocortin 2 receptor accessory protein 2 |
U: 1
|
| MSMP | microseminoprotein, prostate associated |
U: 1
|
| MSN | moesin |
U: 1
D: 2
|
| MSTN | myostatin |
D: 1
|
| MTSS1 | MTSS I-BAR domain containing 1 |
U: 2
D: 1
|
| MYD88 | myeloid differentiation primary response gene 88 |
U: 1
|
| MYO1C | myosin IC |
U: 1
D: 2
|
| MYOD1 | myogenic differentiation 1 |
U: 1
|
| MAP1A | microtubule-associated protein 1 A |
U: 2
D: 1
|
| MECR | mitochondrial trans-2-enoyl-CoA reductase |
D: 1
|
| MMP13 | matrix metallopeptidase 13 |
U: 18
D: 1
|
| MYL12A | myosin, light chain 12A, regulatory, non-sarcomeric |
U: 1
D: 1
|
| MYO5B | myosin VB |
D: 1
|
| NCOA2 | nuclear receptor coactivator 2 |
D: 3
|
| NCOA3 | nuclear receptor coactivator 3 |
U: 1
D: 2
|
| NCOA4 | nuclear receptor coactivator 4 |
U: 2
|
| NCOA7 | nuclear receptor coactivator 7 |
U: 1
D: 2
|
| NCOR2 | nuclear receptor co-repressor 2 |
U: 1
D: 2
|
| NCSTN | nicastrin |
U: 1
|
| NECAB2 | N-terminal EF-hand calcium binding protein 2 |
U: 2
|
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 |
U: 2
D: 1
|
| NEO1 | neogenin |
U: 2
|
| NES | nestin |
U: 2
D: 4
|
| NETO1 | neuropilin (NRP) and tolloid (TLL)-like 1 |
U: 1
D: 1
|
| NETO2 | neuropilin (NRP) and tolloid (TLL)-like 2 |
U: 2
D: 2
|
| NFATC4 | nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 |
U: 2
D: 1
|
| NGF | nerve growth factor |
U: 3
|
| NKX3-1 | NK3 homeobox 1 |
U: 2
|
| NMB | neuromedin B |
U: 1
D: 1
|
| NMU | neuromedin U |
D: 2
|
| NPFF | neuropeptide FF-amide peptide precursor |
U: 1
|
| NPFFR2 | neuropeptide FF receptor 2 |
U: 1
|
| NPPA | natriuretic peptide type A |
U: 3
|
| NPPB | natriuretic peptide type B |
U: 1
|
| NPPC | natriuretic peptide type C |
U: 3
|
| NPTN | neuroplastin |
U: 2
D: 1
|
| NPY | neuropeptide Y |
U: 1
D: 2
|
| NR1H2 | nuclear receptor subfamily 1, group H, member 2 |
U: 2
D: 2
|
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 |
U: 2
|
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 |
D: 1
|
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 |
U: 2
|
| NRG1 | neuregulin 1 |
U: 2
D: 3
|
| NRG2 | neuregulin 2 |
D: 1
|
| NRG3 | neuregulin 3 |
D: 1
|
| NRIP1 | nuclear receptor interacting protein 1 |
U: 2
|
| NRTN | neurturin |
U: 1
|
| NRXN1 | neurexin I |
U: 1
|
| NSD1 | nuclear receptor-binding SET-domain protein 1 |
D: 2
|
| NSF | N-ethylmaleimide sensitive fusion protein |
U: 1
|
| NSG1 | neuron specific gene family member 1 |
U: 3
D: 1
|
| NTF3 | neurotrophin 3 |
U: 1
D: 1
|
| NTF4 | neurotrophin 4 |
U: 1
|
| NTN3 | netrin 3 |
U: 1
D: 1
|
| NTN5 | netrin 5 |
U: 2
|
| NXPH3 | neurexophilin 3 |
U: 1
|
| NXPH4 | neurexophilin 4 |
U: 2
D: 1
|
| NARS | asparaginyl-tRNA synthetase |
U: 1
D: 1
|
| NCL | nucleolin |
D: 1
|
| NEFM | neurofilament, medium polypeptide |
U: 1
|
| NGEF | neuronal guanine nucleotide exchange factor |
U: 1
D: 2
|
| NGFR | nerve growth factor receptor (TNFR superfamily, member 16) |
U: 2
|
| NOL3 | nucleolar protein 3 (apoptosis repressor with CARD domain) |
U: 3
|
| NR1H3 | nuclear receptor subfamily 1, group H, member 3 |
D: 3
|
| NRBF2 | nuclear receptor binding factor 2 |
U: 1
D: 1
|
| NSMAF | neutral sphingomyelinase (N-SMase) activation associated factor |
U: 1
D: 1
|
| NUCB2 | nucleobindin 2 |
U: 1
D: 1
|
| NUP85 | nucleoporin 85 |
U: 2
D: 1
|
| OASL | 2'-5'-oligoadenylate synthetase like |
U: 3
|
| OSM | oncostatin M |
U: 1
|
| OSMR | oncostatin M receptor |
U: 1
D: 1
|
| P2RX4 | purinergic receptor P2X, ligand-gated ion channel 4 |
D: 1
|
| P2RX7 | purinergic receptor P2X 7 |
D: 1
|
| P2RY1 | purinergic receptor P2Y, G-protein coupled 1 |
U: 1
D: 1
|
| P2RY2 | purinergic receptor P2Y, G-protein coupled 2 |
U: 2
D: 1
|
| PADI2 | peptidyl arginine deiminase, type II |
U: 3
|
| PALM | paralemmin |
U: 2
|
| PANX1 | pannexin 1 |
U: 2
|
| PARK7 | Parkinson disease (autosomal recessive, early onset) 7 |
U: 1
D: 2
|
| PARP1 | poly (ADP-ribose) polymerase family, member 1 |
U: 5
D: 8
|
| PCNA | proliferating cell nuclear antigen |
U: 2
D: 6
|
| PCSK1N | proprotein convertase subtilisin/kexin type 1 inhibitor |
U: 4
|
| PCSK9 | proprotein convertase subtilisin/kexin type 9 |
U: 1
D: 1
|
| PDCD6IP | programmed cell death 6 interacting protein |
U: 1
|
| PDE4D | phosphodiesterase 4D |
U: 2
|
| PDGFA | platelet derived growth factor, alpha |
U: 3
|
| PDGFB | platelet derived growth factor, B polypeptide |
U: 4
D: 2
|
| PDGFC | platelet-derived growth factor, C polypeptide |
U: 3
|
| PDGFD | platelet-derived growth factor, D polypeptide |
D: 1
|
| PDGFRA | platelet derived growth factor receptor, alpha polypeptide |
U: 2
D: 2
|
| PDGFRB | platelet derived growth factor receptor, beta polypeptide |
D: 4
|
| PDPK1 | 3-phosphoinositide dependent protein kinase 1 |
U: 2
|
| PDPN | podoplanin |
U: 1
|
| PECR | peroxisomal trans-2-enoyl-CoA reductase |
D: 2
|
| PENK | preproenkephalin |
D: 2
|
| PF4 | platelet factor 4 |
U: 3
D: 1
|
| PGF | placental growth factor |
U: 1
D: 3
|
| PHB | prohibitin |
U: 2
D: 2
|
| PHB2 | prohibitin 2 |
D: 1
|
| PHIP | pleckstrin homology domain interacting protein |
D: 1
|
| PIAS1 | protein inhibitor of activated STAT 1 |
U: 1
D: 1
|
| PIBF1 | progesterone immunomodulatory binding factor 1 |
U: 1
|
| PICALM | phosphatidylinositol binding clathrin assembly protein |
U: 1
|
| PIDD1 | p53-induced death domain protein 1 |
U: 3
|
| PIK3AP1 | phosphoinositide-3-kinase adaptor protein 1 |
U: 1
D: 1
|
| PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
U: 2
D: 3
|
| PIK3R1 | phosphoinositide-3-kinase regulatory subunit 1 |
U: 1
|
| PKN1 | protein kinase N1 |
D: 1
|
| PLA2G1B | phospholipase A2, group IB, pancreas |
U: 1
|
| PLAT | plasminogen activator, tissue |
U: 6
D: 3
|
| PLAUR | plasminogen activator, urokinase receptor |
U: 8
D: 2
|
| PLCG1 | phospholipase C, gamma 1 |
U: 2
D: 1
|
| PLCL1 | phospholipase C-like 1 |
U: 1
D: 1
|
| PLCL2 | phospholipase C-like 2 |
D: 2
|
| PLSCR1 | phospholipid scramblase 1 |
U: 2
D: 1
|
| PLSCR4 | phospholipid scramblase 4 |
U: 3
|
| PLXNB1 | plexin B1 |
U: 2
|
| PLXNC1 | plexin C1 |
U: 1
|
| PNOC | prepronociceptin |
D: 1
|
| POMC | pro-opiomelanocortin-alpha |
U: 1
|
| PPARG | peroxisome proliferator activated receptor gamma |
U: 7
D: 9
|
| PPARGC1A | peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
U: 3
D: 13
|
| PPARGC1B | peroxisome proliferative activated receptor, gamma, coactivator 1 beta |
U: 5
D: 1
|
| PPBP | pro-platelet basic protein |
U: 3
|
| PPID | peptidylprolyl isomerase D |
U: 1
D: 1
|
| PPP1R1B | protein phosphatase 1, regulatory inhibitor subunit 1B |
U: 1
D: 1
|
| PPP2CA | protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform |
D: 2
|
| PRKN | parkin RBR E3 ubiquitin protein ligase |
U: 5
D: 1
|
| PRL | prolactin |
U: 1
|
| PRLR | prolactin receptor |
U: 1
|
| PRNP | prion protein |
U: 3
D: 1
|
| PROX1 | prospero homeobox 1 |
U: 2
|
| PSAP | prosaposin |
U: 3
D: 2
|
| PSCA | prostate stem cell antigen |
U: 2
D: 1
|
| PSEN1 | presenilin 1 |
U: 3
|
| PSMC5 | protease (prosome, macropain) 26S subunit, ATPase 5 |
U: 1
|
| PTEN | phosphatase and tensin homolog |
U: 6
D: 20
|
| PTHLH | parathyroid hormone-like peptide |
U: 1
D: 3
|
| PTK2 | PTK2 protein tyrosine kinase 2 |
U: 1
D: 4
|
| PTK2B | PTK2 protein tyrosine kinase 2 beta |
U: 1
|
| PTK6 | PTK6 protein tyrosine kinase 6 |
D: 1
|
| PTPA | protein phosphatase 2 protein activator |
U: 1
|
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 |
U: 2
|
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 |
U: 1
D: 2
|
| PTPRC | protein tyrosine phosphatase, receptor type, C |
U: 2
D: 2
|
| PTPRD | protein tyrosine phosphatase, receptor type, D |
D: 1
|
| PTPRF | protein tyrosine phosphatase, receptor type, F |
U: 1
D: 1
|
| PTPRJ | protein tyrosine phosphatase, receptor type, J |
U: 1
D: 2
|
| PYCARD | PYD and CARD domain containing |
U: 1
|
| PEBP1 | phosphatidylethanolamine binding protein 1 |
U: 6
|
| PER2 | period circadian clock 2 |
U: 2
|
| PFN1 | profilin 1 |
U: 1
D: 2
|
| PGR | progesterone receptor |
U: 3
D: 2
|
| PLA2G5 | phospholipase A2, group V |
U: 1
D: 1
|
| POU2F1 | POU domain, class 2, transcription factor 1 |
U: 2
D: 1
|
| PRDM4 | PR domain containing 4 |
D: 1
|
| PRKAR2A | protein kinase, cAMP dependent regulatory, type II alpha |
U: 1
D: 2
|
| PSMC3IP | proteasome (prosome, macropain) 26S subunit, ATPase 3, interacting protein |
D: 3
|
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 |
D: 2
|
| RAB8B | RAB8B, member RAS oncogene family |
U: 1
D: 1
|
| RACK1 | receptor for activated C kinase 1 |
D: 1
|
| RAET1E | retinoic acid early transcript 1E |
D: 1
|
| RAET1G | retinoic acid early transcript 1G |
U: 1
|
| RAN | RAN, member RAS oncogene family |
U: 1
D: 4
|
| RAPGEF2 | Rap guanine nucleotide exchange factor (GEF) 2 |
D: 1
|
| RAPSN | receptor-associated protein of the synapse |
U: 1
|
| RARB | retinoic acid receptor, beta |
U: 2
D: 1
|
| RARRES2 | retinoic acid receptor responder (tazarotene induced) 2 |
U: 1
D: 3
|
| RASA1 | RAS p21 protein activator 1 |
U: 1
|
| RASL11B | RAS-like, family 11, member B |
U: 2
D: 2
|
| RB1 | RB transcriptional corepressor 1 |
U: 37
D: 7
|
| REEP1 | receptor accessory protein 1 |
U: 1
D: 1
|
| REEP2 | receptor accessory protein 2 |
U: 3
|
| RELN | reelin |
D: 1
|
| RER1 | retention in endoplasmic reticulum sorting receptor 1 |
U: 1
|
| RGMA | repulsive guidance molecule family member A |
D: 2
|
| RIMBP3 | RIMS binding protein 3 |
U: 1
|
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 |
U: 1
|
| RIPK2 | receptor (TNFRSF)-interacting serine-threonine kinase 2 |
U: 1
D: 1
|
| RND1 | Rho family GTPase 1 |
U: 1
D: 2
|
| RNF126 | ring finger protein 126 |
U: 1
|
| RNF14 | ring finger protein 14 |
U: 1
D: 2
|
| RNF4 | ring finger protein 4 |
U: 1
D: 1
|
| RNF41 | ring finger protein 41 |
U: 1
D: 1
|
| RNF6 | ring finger protein (C3H2C3 type) 6 |
D: 1
|
| RSPO2 | R-spondin 2 |
D: 1
|
| RSPO3 | R-spondin 3 |
U: 2
|
| RTP4 | receptor transporter protein 4 |
U: 2
|
| RUVBL2 | RuvB-like protein 2 |
U: 1
D: 5
|
| RXRA | retinoid X receptor alpha |
U: 1
D: 3
|
| RPL11 | ribosomal protein L11 |
U: 1
D: 1
|
| S100A13 | S100 calcium binding protein A13 |
U: 3
|
| S100A14 | S100 calcium binding protein A14 |
U: 1
|
| S100A4 | S100 calcium binding protein A4 |
U: 3
D: 1
|
| S100A7 | S100 calcium binding protein A7 |
D: 1
|
| S100A8 | S100 calcium binding protein A8 (calgranulin A) |
U: 2
|
| S100A9 | S100 calcium binding protein A9 (calgranulin B) |
U: 2
D: 1
|
| S100B | S100 protein, beta polypeptide, neural |
D: 1
|
| S100P | S100 calcium binding protein P |
U: 2
|
| S1PR1 | sphingosine-1-phosphate receptor 1 |
D: 5
|
| S1PR2 | sphingosine-1-phosphate receptor 2 |
U: 2
D: 1
|
| SAA1 | serum amyloid A 1 |
U: 5
|
| SAG | S-antigen, retina and pineal gland (arrestin) |
D: 1
|
| SAV1 | salvador family WW domain containing 1 |
D: 2
|
| SCP2 | sterol carrier protein 2, liver |
U: 1
|
| SCT | secretin |
U: 2
|
| SDCBP | syndecan binding protein |
U: 1
|
| SELPLG | selectin P ligand |
U: 1
D: 1
|
| SEMA3A | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
D: 1
|
| SEMA3B | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
U: 2
|
| SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
U: 3
D: 1
|
| SEMA3D | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D |
D: 1
|
| SEMA3E | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E |
U: 2
|
| SEMA3F | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
U: 2
D: 1
|
| SEMA3G | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G |
U: 1
|
| SEMA4A | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
D: 2
|
| SEMA4C | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C |
D: 1
|
| SEMA4F | sema domain, immunoglobulin domain (Ig), TM domain, and short cytoplasmic domain |
D: 1
|
| SEMA4G | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G |
U: 2
|
| SEMA5A | sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
U: 1
D: 1
|
| SEMA5B | sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B |
U: 1
D: 1
|
| SEMA6A | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
U: 1
D: 2
|
| SEMA6B | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B |
U: 1
D: 1
|
| SEMA6C | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C |
D: 1
|
| SEMA6D | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
U: 3
D: 1
|
| SEMA7A | sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, (semaphorin) 7A |
U: 2
D: 2
|
| SERPINE1 | serine (or cysteine) peptidase inhibitor, clade E, member 1 |
U: 38
D: 5
|
| SERPINE2 | serine (or cysteine) peptidase inhibitor, clade E, member 2 |
U: 2
D: 1
|
| SH2B3 | SH2B adaptor protein 3 |
D: 1
|
| SH3BP1 | SH3-domain binding protein 1 |
U: 1
|
| SH3GL1 | SH3-domain GRB2-like 1 |
D: 1
|
| SHANK1 | SH3 and multiple ankyrin repeat domains 1 |
U: 1
|
| SHANK3 | SH3 and multiple ankyrin repeat domains 3 |
U: 2
D: 2
|
| SHC1 | src homology 2 domain-containing transforming protein C1 |
U: 7
D: 1
|
| SHISA7 | shisa family member 7 |
U: 2
|
| SIPA1L1 | signal-induced proliferation-associated 1 like 1 |
U: 1
|
| SIRT1 | sirtuin 1 |
U: 12
D: 110
|
| SIVA1 | SIVA1, apoptosis-inducing factor |
D: 2
|
| SLC30A9 | solute carrier family 30 (zinc transporter), member 9 |
D: 1
|
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 |
U: 2
D: 1
|
| SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 |
U: 1
D: 3
|
| SMAD2 | SMAD family member 2 |
U: 2
D: 1
|
| SMAD3 | SMAD family member 3 |
U: 8
D: 2
|
| SMAD6 | SMAD family member 6 |
D: 1
|
| SMAD7 | SMAD family member 7 |
U: 2
D: 1
|
| SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
U: 4
D: 6
|
| SMARCD1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 |
U: 1
D: 3
|
| SMARCD3 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
U: 1
D: 2
|
| SMARCE1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 |
U: 1
D: 2
|
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 |
U: 7
|
| SNX2 | sorting nexin 2 |
U: 1
|
| SNX25 | sorting nexin 25 |
U: 1
|
| SNX4 | sorting nexin 4 |
D: 2
|
| SNX5 | sorting nexin 5 |
D: 2
|
| SOCS1 | suppressor of cytokine signaling 1 |
U: 4
|
| SOCS2 | suppressor of cytokine signaling 2 |
U: 2
D: 1
|
| SORBS1 | sorbin and SH3 domain containing 1 |
U: 3
D: 2
|
| SPG21 | SPG21, maspardin |
D: 1
|
| SPRED1 | sprouty protein with EVH-1 domain 1, related sequence |
U: 1
D: 3
|
| SPRED2 | sprouty-related EVH1 domain containing 2 |
D: 1
|
| SQSTM1 | sequestosome 1 |
U: 15
D: 4
|
| SRC | Rous sarcoma oncogene |
U: 2
D: 6
|
| SRI | sorcin |
U: 1
D: 3
|
| SRPX2 | sushi-repeat-containing protein, X-linked 2 |
U: 6
D: 2
|
| STAT1 | signal transducer and activator of transcription 1 |
U: 12
D: 1
|
| STAT3 | signal transducer and activator of transcription 3 |
U: 18
D: 6
|
| STAT5B | signal transducer and activator of transcription 5B |
U: 4
|
| STOML2 | stomatin like 2 |
D: 2
|
| STRAP | serine/threonine kinase receptor associated protein |
D: 1
|
| STUB1 | STIP1 homology and U-Box containing protein 1 |
U: 2
D: 3
|
| STX1B | syntaxin 1B |
U: 1
|
| STYK1 | serine/threonine/tyrosine kinase 1 |
U: 1
|
| SYK | spleen tyrosine kinase |
U: 3
D: 2
|
| SYT1 | synaptotagmin I |
D: 1
|
| SAA2 | serum amyloid A 2 |
U: 3
|
| SACS | sacsin |
D: 2
|
| SLIT1 | slit guidance ligand 1 |
U: 2
D: 1
|
| SLIT2 | slit guidance ligand 2 |
U: 1
D: 1
|
| SLIT3 | slit guidance ligand 3 |
U: 2
D: 1
|
| SNX27 | sorting nexin family member 27 |
U: 1
|
| SPON2 | spondin 2, extracellular matrix protein |
U: 4
|
| SPRED3 | sprouty-related EVH1 domain containing 3 |
U: 2
|
| SPX | spexin hormone |
U: 1
D: 1
|
| SRA1 | steroid receptor RNA activator 1 |
U: 1
|
| SUMO2 | small ubiquitin-like modifier 2 |
U: 3
D: 1
|
| SYNE1 | spectrin repeat containing, nuclear envelope 1 |
D: 5
|
| TAC1 | tachykinin 1 |
U: 1
|
| TAC3 | tachykinin precursor 3 |
U: 1
D: 2
|
| TACC1 | transforming, acidic coiled-coil containing protein 1 |
U: 3
D: 2
|
| TACC2 | transforming, acidic coiled-coil containing protein 2 |
U: 2
D: 1
|
| TADA3 | transcriptional adaptor 3 |
U: 1
D: 3
|
| TAF10 | TATA-box binding protein associated factor 10 |
U: 1
|
| TAF4 | TATA-box binding protein associated factor 4 |
D: 1
|
| TAF7 | TATA-box binding protein associated factor 7 |
U: 1
|
| TBP | TATA box binding protein |
D: 1
|
| TCF21 | transcription factor 21 |
D: 3
|
| TCF7L2 | transcription factor 7 like 2, T cell specific, HMG box |
U: 1
|
| TF | transferrin |
U: 1
|
| TFR2 | transferrin receptor 2 |
U: 1
D: 1
|
| TGFA | transforming growth factor alpha |
U: 1
D: 1
|
| TGFB1 | transforming growth factor, beta 1 |
U: 49
D: 6
|
| TGFB1I1 | transforming growth factor beta 1 induced transcript 1 |
U: 2
D: 1
|
| TGFB2 | transforming growth factor, beta 2 |
U: 5
D: 1
|
| TGFB3 | transforming growth factor, beta 3 |
U: 1
D: 3
|
| TGFBR1 | transforming growth factor, beta receptor I |
U: 5
|
| TGFBR2 | transforming growth factor, beta receptor II |
U: 4
D: 2
|
| TGFBR3 | transforming growth factor, beta receptor III |
U: 3
D: 2
|
| TGFBR3L | transforming growth factor, beta receptor III-like |
U: 1
|
| THPO | thrombopoietin |
U: 2
D: 1
|
| THRAP3 | thyroid hormone receptor associated protein 3 |
U: 1
D: 1
|
| TIMM50 | translocase of inner mitochondrial membrane 50 |
D: 1
|
| TLR2 | toll-like receptor 2 |
U: 3
D: 1
|
| TLR4 | toll-like receptor 4 |
U: 7
D: 2
|
| TLR5 | toll-like receptor 5 |
U: 1
D: 1
|
| TLR6 | toll-like receptor 6 |
U: 1
D: 1
|
| TLR9 | toll-like receptor 9 |
U: 1
D: 1
|
| TMBIM1 | transmembrane BAX inhibitor motif containing 1 |
U: 1
|
| TMEFF1 | transmembrane protein with EGF like and two follistatin like domains 1 |
U: 1
|
| TNF | tumor necrosis factor |
U: 48
D: 7
|
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 |
U: 5
D: 3
|
| TNFSF11 | tumor necrosis factor (ligand) superfamily, member 11 |
U: 5
|
| TNFSF12 | tumor necrosis factor (ligand) superfamily, member 12 |
U: 1
|
| TNFSF13 | tumor necrosis factor (ligand) superfamily, member 13 |
D: 1
|
| TNFSF13B | tumor necrosis factor (ligand) superfamily, member 13b |
U: 3
D: 4
|
| TNFSF15 | tumor necrosis factor (ligand) superfamily, member 15 |
U: 4
D: 1
|
| TNFSF18 | tumor necrosis factor (ligand) superfamily, member 18 |
U: 1
|
| TNFSF4 | tumor necrosis factor (ligand) superfamily, member 4 |
U: 1
D: 1
|
| TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 |
U: 2
|
| TNFSF9 | tumor necrosis factor (ligand) superfamily, member 9 |
U: 2
|
| TOLLIP | toll interacting protein |
U: 2
|
| TRADD | TNFRSF1A-associated via death domain |
U: 1
|
| TRAF1 | TNF receptor-associated factor 1 |
U: 4
|
| TRAF3 | TNF receptor-associated factor 3 |
U: 2
|
| TRAF4 | TNF receptor associated factor 4 |
U: 1
|
| TRAF5 | TNF receptor-associated factor 5 |
U: 1
D: 2
|
| TRAF6 | TNF receptor-associated factor 6 |
U: 1
D: 3
|
| TRAK1 | trafficking protein, kinesin binding 1 |
U: 1
|
| TRAK2 | trafficking protein, kinesin binding 2 |
U: 2
D: 1
|
| TRAP1 | TNF receptor associated protein 1 |
D: 1
|
| TRIM24 | tripartite motif-containing 24 |
D: 2
|
| TRIM37 | tripartite motif-containing 37 |
U: 1
|
| TRIM68 | tripartite motif-containing 68 |
D: 1
|
| TRIP6 | thyroid hormone receptor interactor 6 |
U: 1
D: 1
|
| TRPC1 | transient receptor potential cation channel, subfamily C, member 1 |
U: 1
|
| TSLP | thymic stromal lymphopoietin |
U: 1
D: 1
|
| TSPOAP1 | TSPO associated protein 1 |
U: 1
|
| TUB | tubby bipartite transcription factor |
U: 1
D: 1
|
| TUBB3 | tubulin, beta 3 class III |
U: 3
D: 3
|
| TULP3 | tubby-like protein 3 |
D: 2
|
| TYK2 | tyrosine kinase 2 |
U: 1
|
| TENM2 | teneurin transmembrane protein 2 |
U: 4
|
| TG | thyroglobulin |
U: 1
D: 1
|
| TIAM1 | T cell lymphoma invasion and metastasis 1 |
U: 3
D: 1
|
| TNS2 | tensin 2 |
U: 1
D: 1
|
| TRAF3IP1 | TRAF3 interacting protein 1 |
U: 2
|
| UBA3 | ubiquitin-like modifier activating enzyme 3 |
D: 1
|
| UBXN2A | UBX domain protein 2A |
D: 1
|
| UCHL1 | ubiquitin carboxy-terminal hydrolase L1 |
U: 1
|
| UFD1 | ubiquitin recognition factor in ER-associated degradation 1 | |
| ULBP1 | UL16 binding protein 1 |
U: 3
D: 1
|
| ULBP2 | UL16 binding protein 2 |
U: 4
|
| ULBP3 | UL16 binding protein 3 |
U: 1
|
| UNC93B1 | unc-93 homolog B1, TLR signaling regulator |
U: 1
D: 1
|
| USP20 | ubiquitin specific peptidase 20 |
U: 1
|
| USP33 | ubiquitin specific peptidase 33 |
U: 1
|
| USP4 | ubiquitin specific peptidase 4 (proto-oncogene) |
D: 1
|
| UTS2 | urotensin 2 |
U: 1
|
| UCN | urocortin |
U: 1
|
| UIMC1 | ubiquitin interaction motif containing 1 |
D: 1
|
| VAV3 | vav 3 oncogene |
U: 3
D: 2
|
| VDR | vitamin D (1,25-dihydroxyvitamin D3) receptor |
U: 1
D: 2
|
| VEGFA | vascular endothelial growth factor A |
U: 10
D: 5
|
| VEGFC | vascular endothelial growth factor C |
D: 1
|
| VIP | vasoactive intestinal polypeptide |
U: 1
|
| VPS35 | VPS35 retromer complex component |
U: 1
|
| VTCN1 | V-set domain containing T cell activation inhibitor 1 |
U: 1
|
| WBP2 | WW domain binding protein 2 |
U: 1
D: 1
|
| WIPI1 | WD repeat domain, phosphoinositide interacting 1 |
U: 2
D: 1
|
| WLS | wntless WNT ligand secretion mediator |
U: 1
|
| WNT3A | wingless-type MMTV integration site family, member 3A |
U: 2
|
| WNT5A | wingless-type MMTV integration site family, member 5A |
U: 4
|
| WNT5B | wingless-type MMTV integration site family, member 5B |
U: 1
|
| WNT7A | wingless-type MMTV integration site family, member 7A |
U: 1
D: 1
|
| WNT1 | wingless-type MMTV integration site family, member 1 |
U: 1
D: 1
|
| WNT11 | wingless-type MMTV integration site family, member 11 |
U: 1
|
| WNT16 | wingless-type MMTV integration site family, member 16 |
U: 1
D: 1
|
| WNT2 | wingless-type MMTV integration site family, member 2 |
D: 4
|
| WNT2B | wingless-type MMTV integration site family, member 2B |
U: 2
D: 1
|
| WNT3 | wingless-type MMTV integration site family, member 3 |
U: 3
D: 1
|
| WNT4 | wingless-type MMTV integration site family, member 4 |
U: 1
D: 3
|
| WNT6 | wingless-type MMTV integration site family, member 6 |
U: 1
|
| WNT7B | wingless-type MMTV integration site family, member 7B |
U: 3
D: 3
|
| WNT9A | wingless-type MMTV integration site family, member 9A |
U: 2
|
| XCL1 | chemokine (C motif) ligand 1 |
U: 1
D: 1
|
| YES1 | YES proto-oncogene 1, Src family tyrosine kinase |
U: 1
D: 1
|
| YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide |
U: 1
|
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide |
U: 1
|
| ZBTB7A | zinc finger and BTB domain containing 7a |
U: 2
D: 3
|
| ZNHIT3 | zinc finger HIT-type containing 3 |
D: 1
|